Clinical Trials Logo

Uterine Prolapse clinical trials

View clinical trials related to Uterine Prolapse.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03714607 Active, not recruiting - Cystocele Clinical Trials

Laser Therapy in Managing Vaginal Prolapse

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

NCT ID: NCT03658395 Active, not recruiting - Vaginal Prolapse Clinical Trials

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

Start date: July 19, 2018
Phase: N/A
Study type: Interventional

Participants who undergo laparoscopic sacrocolpopexy (LSCP) plus posterior repair (PR) will demonstrate greater improvement bowel symptom scores compared to participants who undergo LSCP alone at 3 months postoperatively.

NCT ID: NCT03436979 Active, not recruiting - Clinical trials for Uterine Prolapse Without Vaginal Wall Prolapse

The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse

Start date: January 1, 2018
Phase:
Study type: Observational

The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.

NCT ID: NCT02921451 Active, not recruiting - Uterine Prolapse Clinical Trials

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse

Start date: August 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the long term performance of Restorelle system for the treatment of uterine prolapse.

NCT ID: NCT02231099 Active, not recruiting - Clinical trials for Pelvic Organ Prolapse

Effectiveness Prolift+M Versus Conventional Vaginal Prolapse Surgery

VROUW2
Start date: January 2011
Phase: N/A
Study type: Interventional

Pelvic organ prolapse is highly prevalent in the female population. The recurrence rate of pelvic organ prolapse after surgical treatment is high. This emphasizes the clinical need for improvement of the surgical techniques currently used. Placement of a mesh aims at reducing the recurrence rate. In this study the investigators compare the effectiveness of the Tension free Vaginal mesh + Monocryl with standard vaginal prolapse surgery without mesh.

NCT ID: NCT01097200 Active, not recruiting - Cystocele Clinical Trials

Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse

Start date: May 2010
Phase: N/A
Study type: Interventional

Pelvic prolapse is one of the most frequent pathology in Gynecology. Recurrency of the prolapse after primary surgery is relatively high, 15-30%. Sacrocolpopexy has showed to be effective but it requires a long learning curves and is more aggressive. New meshes techniques seem to be effective, as well, with less learning curve but they are expensive and there are no randomize studies published. The investigators aim is to compare both techniques in terms of: anatomical and functional efficacy, cost, operating time and complications.

NCT ID: NCT00564044 Active, not recruiting - Clinical trials for Urinary Incontinence

The Immune Reactivity of Biofilms in Vaginal Mesh Erosion.

Start date: August 2007
Phase: N/A
Study type: Interventional

Aging, birth trauma and extensive pelvic surgery are the causes known to cause advanced pelvic organ prolaspe, fecal as well as urinary incontinence. Surgical treatment is the last resort to manage the above-mentioned clinical manifestations of pelvic floor disorders except the subject is too frail to receive operation. In order to improve the outcome of reconstructive pelvic surgery, reinforcement with synthetic mesh or biological material is the modern trend in pelvic repair. Unfortunately no prosthesis including synthetic or biological is ideal because vaginal erosion with mesh extrusion which is the subject of this protocol and other complications were reported continuously. As per the literature, the rate for mesh vaginal extrusion ranged between 2.4 and 17% when polypropylene which is the most popular synthetic material used for the mid-urethral sling or pelvic reconstructive surgery to date. The causes of this complication are still controversial which include rejection, poor quality of tissue, surgical artifact, material of mesh and etc. A prospective controlled study for the investigation of the cause for mesh vaginal erosion was conducted and the results revealed evidences of immune reactivity after mesh implantation, albeit the evidence was not solid (Am J Obstet Gynecol 2004; 191(6): 1868-1874 ). As per the pilot study initially done by us to determine the biofilm-related-infection, we have found bacterial biofilm could adhere to surfaces and interfaces, i.e. bacteria located in the cells just beneath the contacting surfaces in the electron microscopic (EM) analysis. In addition, soon after bacteria infection, proteins in biofilm undergo conformational changes, making them immunogenic and triggers a typical inflammatory response leading to activation of the complement system. Thus, we plan to use CD (clusters of differentiation) antigens - 4, 8, 20, 25, 40, 68 and quantitative analysis of FoxP3 to determine the function of regulatory T cells in the immune response. In addition, bacterial culture and EM analysis of the excised mesh with surrounding vagina tissue will be performed for further analysis of biofilms.

NCT ID: NCT00442247 Active, not recruiting - Vaginal Prolapse Clinical Trials

A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse

Start date: September 2004
Phase: N/A
Study type: Interventional

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced.